PLx Pharma  logo
PLx Pharma PLXP
$ 0.09 -27.8%

Quarterly report 2022-Q3
added 11-10-2022

report update icon

PLx Pharma Income Statement 2011-2024 | PLXP

Annual Income Statement PLx Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

118 M 49.3 M 51.6 M 47 M 45.6 M 15 M 76.3 M 86.4 M - - -

Shares

23.7 M 9.16 M 8.92 M 8.73 M 7.02 M 1.3 M 1.18 M 981 K - - -

Historical Prices

5.05 7.43 5.68 4.85 6.4 8.8 60 114 - - -

Net Income

-46.1 M -15.2 M -20.5 M 896 K -15.3 M -21.3 M -18.7 M -13.6 M -4.01 M -1.84 M -

Revenue

8.21 M 30.4 K 565 K 753 K 779 K - - - - - -

Cost of Revenue

4.8 M - - - - - - - - - -

Gross Profit

3.4 M 30.4 - - - - - - - - -

Operating Income

-40.8 M -13.5 M -14.2 M -11 M -15.8 M -4.81 M -18.8 M -13.6 M -4.01 M - -

Interest Expense

- - - - - - - - - - -

EBITDA

-40.7 M -13 M -14 M -10.8 M -13.4 M -21.4 M -18.8 M -13.6 M -4.01 M -1.84 M -

Operating Expenses

44.2 M 13.5 M 14.8 M 11.7 M 14.3 M 21.4 M 18.8 M 13.6 M - - -

General and Administrative Expenses

40 M 9.15 M 10 M 7.79 M 10.2 M 8.61 M 7.48 M 4.68 M 2.28 M 999 K -

All numbers in USD currency

Quarterly Income Statement PLx Pharma

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 28.6 M 27.7 M 27.5 M 27.5 M 26.9 M 23.6 M 16.4 M 13.9 M 9.16 M 9.16 M 9.16 M 9.16 M 8.92 M 8.78 M 8.75 M 8.74 M 8.74 M 8.73 M 8.73 M 8.72 M 8.7 M 6.16 M 4.38 M 4.38 M 4.38 M 4.38 M 10.3 M 10.3 M 10.3 M 8.58 M 8.55 M 8.54 M 8.54 M 8.54 M 5.75 M - 4.77 M 4.43 M 4.37 M - - - - - - - -

Net Income

- -8.5 M -11.9 M -10.8 M - -21.6 M -16.5 M -11.5 M - -3.13 M -5.6 M 1.5 M - 1.7 M -9.35 M -10.9 M - -3.43 M -3.6 M 4.98 M - -3.8 M -2.24 M -1.43 M - -1.08 M -1.47 M -5.82 M - -5.02 M -4.03 M -4.19 M - -3.84 M -3.92 M -2.54 M - -991 K -363 K -4.01 M - - - - - - - -

Revenue

- 386 K 483 K 2.08 M - 6.62 M - - - - 27.9 K 2.52 K - 41.1 K 183 K 318 K - 217 K 167 K 81.5 K - 62.3 K 376 K - - 20 K 20 K - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- 1.46 M 820 K 1.17 M - 3.91 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- -1.07 M -337 K 914 K - 2.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- -10.8 M -14.5 M -18.2 M - -9.86 M -6.48 M -3.6 M - -3.19 M -3.57 M -3 M - -3.68 M -3.85 M -2.92 M - -2.8 M -2.4 M -3.24 M - -3.92 M -4.28 M -1.35 M - -1.05 M -1.44 M -5.83 M - -5.03 M -4.03 M -4.19 M - -3.84 M -3.92 M -2.54 M - -991 K -363 K -407 K - - - - - - - -

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- -10.7 M -14.5 M -18.2 M - -9.78 M -6.42 M -3.57 M - -3.09 M -3.51 M -2.97 M - -3.55 M -3.75 M -2.86 M - -2.66 M -2.31 M -3.2 M - -3.91 M -4.27 M -1.35 M - -1.05 M -1.44 M -5.83 M - -5.03 M -4.03 M -4.19 M - -3.84 M -3.92 M -2.54 M - -991 K -363 K -407 K - - - - - - - -

Operating Expenses

- 9.76 M 14.2 M 19.1 M - 12.6 M 6.48 M 3.6 M - 3.19 M 3.6 M 3.01 M - 3.72 M 4.03 M 3.24 M - 3.02 M 2.56 M 3.32 M - 3.98 M 4.65 M 1.35 M - 1.05 M 1.46 M 5.83 M - 5.03 M 4.03 M 4.19 M - 3.84 M 3.92 M 2.54 M - 991 K 363 K 407 K - - - - - - - -

General and Administrative Expenses

- 9.14 M 13.6 M 18.5 M - 11 M 5.5 M 2.64 M - 1.98 M 2.21 M 2.49 M - 2.5 M 2.43 M 2.24 M - 1.8 M 1.83 M 2.24 M - 3.02 M 4.02 M 1.22 M - 1.04 M 1.45 M 2.25 M - 1.57 M 1.74 M 2.48 M - 1.31 M 1.33 M 727 K - 355 K 329 K 284 K - - - - - - - -

All numbers in USD currency